Brazil’s health regulatory agency said
Tuesday it had approved the Pfizer-BioNTech Covid-19 vaccine for widespread
use, as the country races to secure enough doses to contain one of the
world’s worst outbreaks.
“It gives me great pleasure to announce that after a 17-day review,
(regulators) have granted the first approval in the Americas for widespread
use of a vaccine against Covid-19,” said Antonio Barra Torres, the director
of federal health regulator Anvisa, underlining that the approval was
definitive and not only for emergency use.
However, the vaccine is not yet available in Brazil, which is so far using
two others: Chinese-developed CoronaVac and one developed by Oxford
University and British-Swedish pharmaceutical firm AstraZeneca.
Source: Bangladesh Sangbad Sangstha (BSS)